EZZ Life Science Holdings Ltd
ASX:EZZ
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.46
4.96
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one EZZ stock under the Base Case scenario is 2.05 AUD. Compared to the current market price of 2.61 AUD, EZZ Life Science Holdings Ltd is Overvalued by 22%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
EZZ Life Science Holdings Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for EZZ cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
EZZ Life Science Holdings Ltd
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
EZZ Life Science Holdings Ltd
Balance Sheet Decomposition
EZZ Life Science Holdings Ltd
Current Assets | 24.9m |
Cash & Short-Term Investments | 19m |
Receivables | 2.7m |
Other Current Assets | 3.2m |
Non-Current Assets | 640.4k |
PP&E | 621.5k |
Intangibles | 18.9k |
Other Non-Current Assets | -10 |
Current Liabilities | 4.2m |
Accounts Payable | 2.7m |
Accrued Liabilities | 39.7k |
Other Current Liabilities | 1.4m |
Non-Current Liabilities | 51k |
Other Non-Current Liabilities | 51k |
Earnings Waterfall
EZZ Life Science Holdings Ltd
Revenue
|
66.4m
AUD
|
Cost of Revenue
|
-15.5m
AUD
|
Gross Profit
|
50.9m
AUD
|
Operating Expenses
|
-38.9m
AUD
|
Operating Income
|
12.1m
AUD
|
Other Expenses
|
-5.1m
AUD
|
Net Income
|
7m
AUD
|
Free Cash Flow Analysis
EZZ Life Science Holdings Ltd
AUD | |
Free Cash Flow | AUD |
EZZ Profitability Score
Profitability Due Diligence
EZZ Life Science Holdings Ltd's profitability score is 79/100. The higher the profitability score, the more profitable the company is.
Score
EZZ Life Science Holdings Ltd's profitability score is 79/100. The higher the profitability score, the more profitable the company is.
EZZ Solvency Score
Solvency Due Diligence
EZZ Life Science Holdings Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Score
EZZ Life Science Holdings Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EZZ Price Targets Summary
EZZ Life Science Holdings Ltd
Dividends
Current shareholder yield for EZZ is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
EZZ Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
EZZ Life Science Holdings Ltd. engages in wholesale distributor of skin care products under the EAORON brand to pharmacies, supermarkets and specialist retailers. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-03-03. The firm is wholesale distributor of EAORON skin care products for the Australian and New Zealand markets. The company develops, manufactures and distributes genetic technology enabled consumer health products under its own brand, EZZ. The EAORON brand comprises of five product lines, including Hyaluronic Series, Facial Mask Series, Crystal White Series, Specific Care Series and Anti-Sugar Series. The EZZ products cover market segments, including vitamin and dietary supplements, sports nutrition, wright management and wellbeing, herbal/ traditional and pediatric consumer health products.
Contact
IPO
Employees
Officers
The intrinsic value of one EZZ stock under the Base Case scenario is 2.05 AUD.
Compared to the current market price of 2.61 AUD, EZZ Life Science Holdings Ltd is Overvalued by 22%.